• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羟基硫代吡啶酮相对于羟基吡啶酮及其有机钌配合物具有高抗增殖活性。

High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium Complexes.

作者信息

Shakil Md Salman, Parveen Shahida, Rana Zohaib, Walsh Fearghal, Movassaghi Sanam, Söhnel Tilo, Azam Mayur, Shaheen Muhammad Ashraf, Jamieson Stephen M F, Hanif Muhammad, Rosengren Rhonda J, Hartinger Christian G

机构信息

Department of Pharmacology and Toxicology, University of Otago, PO Box 56, Dunedin 9016, New Zealand.

School of Chemical Sciences, University of Auckland, Private Bag 92019, Auckland 1142, New Zealand.

出版信息

Biomedicines. 2021 Jan 27;9(2):123. doi: 10.3390/biomedicines9020123.

DOI:10.3390/biomedicines9020123
PMID:33513800
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7912191/
Abstract

Hydroxypyr(id)ones are a pharmaceutically important class of compounds that have shown potential in diverse areas of drug discovery. We investigated the 3-hydroxy-4-pyridones - and 3-hydroxy-4-thiopyridones - as well as their Ru(η--cymene)Cl complexes -, and report here the molecular structures of and as determined by X-ray diffraction analysis. Detailed cell biological investigations revealed potent cytotoxic activity, in particular of the 3-hydroxy-4-thiopyridones -, while the Ru complexes of both compound types were less potent, despite still showing antiproliferative activity in the low μM range. The compounds did not modulate the cell cycle distribution of cancer cells but were cytostatic in A549 and cytotoxic in NCI-H522 non-small lung cancer cells, among other effects on cancer cells.

摘要

羟基吡啶酮是一类在药学上很重要的化合物,已在药物研发的多个领域展现出潜力。我们研究了3-羟基-4-吡啶酮和3-羟基-4-硫代吡啶酮,以及它们的Ru(η⁶-对异丙基苯)Cl配合物,并在此报告通过X射线衍射分析确定的[具体化合物1]和[具体化合物2]的分子结构。详细的细胞生物学研究揭示了其强大的细胞毒性活性,特别是3-羟基-4-硫代吡啶酮的活性,而这两种化合物类型的Ru配合物活性较弱,尽管在低 microM范围内仍显示出抗增殖活性。这些化合物没有调节癌细胞的细胞周期分布,但对癌细胞有其他影响,在A549细胞中具有细胞生长抑制作用,在NCI-H522非小细胞肺癌细胞中具有细胞毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/717029986f88/biomedicines-09-00123-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/3610fd48a8a8/biomedicines-09-00123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/fa660153c2e0/biomedicines-09-00123-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/e4affd5788c5/biomedicines-09-00123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/e03915f05266/biomedicines-09-00123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/8136f83643a7/biomedicines-09-00123-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/7f4268e08037/biomedicines-09-00123-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/23bf9f4b8465/biomedicines-09-00123-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/b8f88d1cbe97/biomedicines-09-00123-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/717029986f88/biomedicines-09-00123-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/3610fd48a8a8/biomedicines-09-00123-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/fa660153c2e0/biomedicines-09-00123-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/e4affd5788c5/biomedicines-09-00123-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/e03915f05266/biomedicines-09-00123-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/8136f83643a7/biomedicines-09-00123-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/7f4268e08037/biomedicines-09-00123-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/23bf9f4b8465/biomedicines-09-00123-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/b8f88d1cbe97/biomedicines-09-00123-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61d/7912191/717029986f88/biomedicines-09-00123-g008.jpg

相似文献

1
High Antiproliferative Activity of Hydroxythiopyridones over Hydroxypyridones and Their Organoruthenium Complexes.羟基硫代吡啶酮相对于羟基吡啶酮及其有机钌配合物具有高抗增殖活性。
Biomedicines. 2021 Jan 27;9(2):123. doi: 10.3390/biomedicines9020123.
2
Is the reactivity of M(II)-arene complexes of 3-hydroxy-2(1H)-pyridones to biomolecules the anticancer activity determining parameter?3-羟基-2(1H)-吡啶酮的 M(II)-芳基配合物与生物分子的反应性是否是抗癌活性的决定因素?
Inorg Chem. 2010 Sep 6;49(17):7953-63. doi: 10.1021/ic1009785.
3
Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol.发现含5,7-二卤代-2-甲基-8-喹啉醇的有机金属钌(II)-芳烃配合物具有高体外和体内抗肿瘤活性。
Dalton Trans. 2019 Apr 16;48(16):5352-5360. doi: 10.1039/c9dt00866g.
4
Highly Cytotoxic Ruthenium(II)-Arene Complexes from Bulky 1-Pyrenylphosphane Ligands.具有高细胞毒性的钌(II)-芳基配合物来自大位阻的 1-联吡啶基膦配体。
Inorg Chem. 2018 Dec 3;57(23):14786-14797. doi: 10.1021/acs.inorgchem.8b02541. Epub 2018 Nov 16.
5
The in vitro antitumor activity of arene-ruthenium(II) curcuminoid complexes improves when decreasing curcumin polarity.当降低姜黄素极性时,芳烃钌(II)类姜黄素配合物的体外抗肿瘤活性会提高。
J Inorg Biochem. 2016 Sep;162:44-51. doi: 10.1016/j.jinorgbio.2016.06.002. Epub 2016 Jun 4.
6
Hydrogen bonding and anticancer properties of water-soluble chiral -cymene Ru(II) compounds with amino-oxime ligands.具有氨基肟配体的水溶性手性对异丙基苯钌(II)化合物的氢键作用及抗癌特性
Eur J Inorg Chem. 2015 May;2015(13):2295-2307. doi: 10.1002/ejic.201500097. Epub 2015 Apr 9.
7
Tuning the cytotoxicity of ruthenium(ii) para-cymene complexes by mono-substitution at a triphenylphosphine/phenoxydiphenylphosphine ligand.通过在三苯基膦/苯氧基二苯基膦配体上进行单取代来调节钌(II)对异丙基苯配合物的细胞毒性。
Dalton Trans. 2017 Dec 21;46(47):16589-16604. doi: 10.1039/c7dt03385k. Epub 2017 Nov 22.
8
Luminescent piano-stool complexes incorporating 1-(4-cyanophenyl)imidazole: synthesis, spectral, and structural studies.包含1-(4-氰基苯基)咪唑的发光钢琴凳配合物:合成、光谱和结构研究。
Inorg Chem. 2004 Dec 27;43(26):8600-8. doi: 10.1021/ic049256m.
9
Reactions of [(eta(6)-arene)RuCl(2)](2) with Aromatic Phosphines Containing Methoxy Groups in 2,6-Positions.[(η⁶-芳烃)RuCl₂]₂与2,6位含甲氧基的芳基膦的反应
Inorg Chem. 1996 Apr 10;35(8):2329-2336. doi: 10.1021/ic950625b.
10
The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.联吡啶和联吡啶二醇钌(II)芳烃配合物的化学性质对比及其对癌细胞的细胞毒性
Inorg Chem. 2008 Dec 15;47(24):11470-86. doi: 10.1021/ic801361m.

引用本文的文献

1
Hydroxypyrone derivatives in drug discovery: from chelation therapy to rational design of metalloenzyme inhibitors.药物研发中的羟基吡喃酮衍生物:从螯合疗法到金属酶抑制剂的合理设计
RSC Med Chem. 2022 Jul 29;13(10):1127-1149. doi: 10.1039/d2md00175f. eCollection 2022 Oct 19.
2
Metal-Based Complexes in Cancer Treatment.癌症治疗中的金属基配合物
Biomedicines. 2022 Oct 14;10(10):2573. doi: 10.3390/biomedicines10102573.
3
Ru(ii)arene(N^N bpy/phen)-based RAPTA complexes for anti-tumour activity in human glioblastoma cancer cell lines and toxicity studies in a zebrafish model.

本文引用的文献

1
Introducing -, -, and -donor leaving groups: an investigation of the chemical and biological properties of ruthenium, rhodium and iridium thiopyridone piano stool complexes.引入 -、- 和 - 供体离去基团:对钌、铑和铱硫代吡啶钢琴凳配合物的化学和生物学性质的研究。
Dalton Trans. 2020 Nov 17;49(44):15693-15711. doi: 10.1039/d0dt03165h.
2
A Multitargeted Approach: Organorhodium Anticancer Agent Based on Vorinostat as a Potent Histone Deacetylase Inhibitor.一种多靶点方法:基于伏立诺他的新型有机铑抗癌剂作为有效的组蛋白去乙酰化酶抑制剂。
Angew Chem Int Ed Engl. 2020 Aug 17;59(34):14609-14614. doi: 10.1002/anie.202005758. Epub 2020 Jun 17.
3
基于钌(II)芳烃(N^N联吡啶/菲咯啉)的RAPTA配合物在人胶质母细胞瘤癌细胞系中的抗肿瘤活性及斑马鱼模型中的毒性研究
RSC Adv. 2022 Jun 29;12(29):18911-18922. doi: 10.1039/d2ra02677e. eCollection 2022 Jun 22.
4
Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies.金纳米材料在血液系统恶性肿瘤中的诊疗潜力
Cancers (Basel). 2022 Jun 21;14(13):3047. doi: 10.3390/cancers14133047.
5
Ruthenium Complexes: An Alternative to Platinum Drugs in Colorectal Cancer Treatment.钌配合物:结直肠癌治疗中铂类药物的替代物
Pharmaceutics. 2021 Aug 19;13(8):1295. doi: 10.3390/pharmaceutics13081295.
Systematic Development and Optimization of Inhalable Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment.
用于非小细胞肺癌治疗的可吸入吡非尼酮脂质体的系统开发与优化
Pharmaceutics. 2020 Feb 28;12(3):206. doi: 10.3390/pharmaceutics12030206.
4
Plumbagin engenders apoptosis in lung cancer cells via caspase-9 activation and targeting mitochondrial-mediated ROS induction.白花丹素通过 caspase-9 的激活和靶向线粒体介导的 ROS 诱导诱导肺癌细胞凋亡。
Arch Pharm Res. 2020 Feb;43(2):242-256. doi: 10.1007/s12272-020-01221-6. Epub 2020 Feb 7.
5
Understanding Failure and Improving Treatment Using HDAC Inhibitors for Prostate Cancer.了解前列腺癌治疗失败原因并利用组蛋白去乙酰化酶抑制剂改善治疗效果
Biomedicines. 2020 Jan 30;8(2):22. doi: 10.3390/biomedicines8020022.
6
Functionalization of Ruthenium(II)(η -p-cymene)(3-hydroxy-2-pyridone) Complexes with (Thio)Morpholine: Synthesis and Bioanalytical Studies.钌(II)(η-对异丙基苯)(3-羟基-2-吡啶酮)配合物与(硫代)吗啉的功能化:合成与生物分析研究
Chempluschem. 2017 Jun;82(6):841-847. doi: 10.1002/cplu.201700050. Epub 2017 Apr 5.
7
Synthesis, Modification, and Biological Evaluation of a Library of Novel Water-Soluble Thiopyridone-Based Organometallic Complexes and Their Unexpected (Biological) Behavior.新型水溶性噻吡啶基有机金属配合物库的合成、修饰及生物学评价及其意外(生物学)行为。
Chemistry. 2020 Apr 24;26(24):5419-5433. doi: 10.1002/chem.201905546. Epub 2020 Apr 6.
8
Mechanisms of suppression of cell growth by dual inhibition of ALK and MEK in ALK-positive non-small cell lung cancer.ALK 阳性非小细胞肺癌中双重抑制 ALK 和 MEK 抑制细胞生长的机制。
Sci Rep. 2019 Dec 11;9(1):18842. doi: 10.1038/s41598-019-55376-4.
9
Anticancer organorhodium and -iridium complexes with low toxicity in vivo but high potency in vitro: DNA damage, reactive oxygen species formation, and haemolytic activity.体内低毒性但体外高活性的抗癌有机铑和铱配合物:DNA 损伤、活性氧形成和溶血活性。
Chem Commun (Camb). 2019 Oct 3;55(80):12016-12019. doi: 10.1039/c9cc03822a.
10
Deferiprone: Pan-selective Histone Lysine Demethylase Inhibition Activity and Structure Activity Relationship Study.地拉罗司:泛选择性组蛋白赖氨酸去甲基酶抑制活性及构效关系研究。
Sci Rep. 2019 Mar 18;9(1):4802. doi: 10.1038/s41598-019-39214-1.